| 08:00-08:05 | 致辞 |
致辞 |
|||||
| 08:05-08:20 | 专题发言 |
直肠癌手术的多中心真实世界研究 |
|
||||
| 08:20-08:35 | 专题发言 |
结直肠癌手术风险模型: 研究与验证 |
|
||||
| 08:35-08:50 | 专题发言 |
腹腔镜直肠癌手术:基于大模型的AI研究 |
|
||||
| 08:50-09:05 | 专题发言 |
梗阻性左半结肠癌SEMS支架植入联合新辅助化疗:治疗新选择? |
|
||||
| 09:05-09:15 | 论文发言 |
Chemoradiotherapy (CRT) followed by sequential tislelizumab (TIS) + CAPOX and TIS for organ preservation in low rectal cancer (RELIEVE-01): primary results |
|
||||
| 09:15-09:25 | 论文发言 |
Perfusion outcomes with indocyanine green imaging in laparoscopic total mesorectal excision for rectal cancer (POSTER): a randomised controlled trial |
|
||||
| 09:25-09:40 | 讨论 |
提问与讨论 |
|||||
| 09:50-09:55 | 致辞 |
致辞 |
|
||||
| 09:55-10:10 | 专题发言 |
Global Trends In Robotic Surgery-the Rise of Modular Platforms |
|
||||
| 10:10-10:25 | 专题发言 |
梗阻性左半结肠癌SEMS支架植入联合新辅助化疗:治疗新选择? |
|
||||
| 10:25-10:40 | 专题发言 |
直肠癌新辅助放化疗联合PD-1免疫治疗:研究及证据 |
|
||||
| 10:40-10:55 | 专题发言 |
直肠癌新辅助化疗联合免疫治疗(免放疗):未来的新方向? |
|
||||
| 10:55-11:10 | 专题发言 |
直肠癌新辅助放化疗后nCR+局部切除:馅饼or陷阱? |
|
||||
| 11:10-11:25 | 专题发言 |
腹腔镜右半结肠癌手术:AI大模型训练与标准化手术培训 |
|
||||
| 11:25-11:40 | 讨论 |
提问与讨论 |
|||||